Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 13.4 Billion CNY | -34.12% |
| 2022 | 20.28 Billion CNY | 55.03% |
| 2021 | 13.08 Billion CNY | 22.85% |
| 2020 | 10.64 Billion CNY | 25.98% |
| 2019 | 8.45 Billion CNY | 21.33% |
| 2018 | 6.96 Billion CNY | 39.22% |
| 2017 | 5 Billion CNY | 30.86% |
| 2016 | 3.82 Billion CNY | 105.79% |
| 2015 | 1.85 Billion CNY | 39.18% |
| 2014 | 1.33 Billion CNY | 31.48% |
| 2013 | 1.01 Billion CNY | 43.75% |
| 2012 | 706.41 Million CNY | 46.42% |
| 2011 | 482.47 Million CNY | 40.55% |
| 2010 | 343.27 Million CNY | 30.4% |
| 2009 | 263.25 Million CNY | 47.65% |
| 2008 | 178.29 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 3.23 Billion CNY | 9.18% |
| 2024 Q1 | 2.96 Billion CNY | -4.58% |
| 2024 Q3 | 3.03 Billion CNY | -6.03% |
| 2023 FY | 13.36 Billion CNY | -34.12% |
| 2023 Q3 | 3.45 Billion CNY | -4.42% |
| 2023 Q2 | 3.61 Billion CNY | 11.7% |
| 2023 Q4 | 3.1 Billion CNY | -10.0% |
| 2023 Q1 | 3.23 Billion CNY | -30.54% |
| 2022 Q3 | 4.87 Billion CNY | -20.11% |
| 2022 Q1 | 4.64 Billion CNY | 24.15% |
| 2022 FY | 20.28 Billion CNY | 55.03% |
| 2022 Q4 | 4.65 Billion CNY | -4.58% |
| 2022 Q2 | 6.1 Billion CNY | 31.31% |
| 2021 FY | 13.08 Billion CNY | 22.85% |
| 2021 Q1 | 2.86 Billion CNY | -9.71% |
| 2021 Q4 | 3.74 Billion CNY | 5.57% |
| 2021 Q3 | 3.54 Billion CNY | 21.35% |
| 2021 Q2 | 2.92 Billion CNY | 1.91% |
| 2020 Q2 | 2.94 Billion CNY | 91.84% |
| 2020 Q4 | 3.17 Billion CNY | 5.92% |
| 2020 FY | 10.64 Billion CNY | 25.98% |
| 2020 Q3 | 2.99 Billion CNY | 1.99% |
| 2020 Q1 | 1.53 Billion CNY | -31.67% |
| 2019 Q4 | 2.24 Billion CNY | 1.24% |
| 2019 FY | 8.45 Billion CNY | 21.33% |
| 2019 Q1 | 1.83 Billion CNY | -11.79% |
| 2019 Q2 | 2.15 Billion CNY | 17.6% |
| 2019 Q3 | 2.21 Billion CNY | 2.64% |
| 2018 Q2 | 1.74 Billion CNY | 44.36% |
| 2018 Q1 | 1.2 Billion CNY | -8.98% |
| 2018 Q3 | 1.93 Billion CNY | 10.59% |
| 2018 Q4 | 2.08 Billion CNY | 7.79% |
| 2018 FY | 6.96 Billion CNY | 39.22% |
| 2017 Q1 | 1.04 Billion CNY | -14.94% |
| 2017 Q3 | 1.35 Billion CNY | 6.4% |
| 2017 Q4 | 1.32 Billion CNY | -2.05% |
| 2017 FY | 5 Billion CNY | 30.86% |
| 2017 Q2 | 1.27 Billion CNY | 22.09% |
| 2016 FY | 3.82 Billion CNY | 105.79% |
| 2016 Q4 | 1.22 Billion CNY | 26.8% |
| 2016 Q3 | 968.14 Million CNY | -2.48% |
| 2016 Q2 | 992.73 Million CNY | 56.21% |
| 2016 Q1 | 635.51 Million CNY | 15.49% |
| 2015 Q3 | 494.66 Million CNY | 2.14% |
| 2015 Q4 | 550.28 Million CNY | 11.24% |
| 2015 Q1 | 328.91 Million CNY | -2.56% |
| 2015 FY | 1.85 Billion CNY | 39.18% |
| 2015 Q2 | 484.3 Million CNY | 47.24% |
| 2014 Q3 | 372.29 Million CNY | -0.04% |
| 2014 FY | 1.33 Billion CNY | 31.48% |
| 2014 Q1 | 252.77 Million CNY | -8.87% |
| 2014 Q2 | 372.45 Million CNY | 47.35% |
| 2014 Q4 | 337.56 Million CNY | -9.33% |
| 2013 Q4 | 277.37 Million CNY | 0.6% |
| 2013 FY | 1.01 Billion CNY | 43.75% |
| 2013 Q1 | 186.56 Million CNY | -5.81% |
| 2013 Q2 | 275.82 Million CNY | 47.84% |
| 2013 Q3 | 275.71 Million CNY | -0.04% |
| 2012 Q2 | 190.1 Million CNY | 50.94% |
| 2012 Q4 | 198.06 Million CNY | 2.99% |
| 2012 Q3 | 192.3 Million CNY | 1.16% |
| 2012 Q1 | 125.94 Million CNY | -9.5% |
| 2012 FY | 706.41 Million CNY | 46.42% |
| 2011 Q4 | 139.16 Million CNY | 9.38% |
| 2011 FY | 482.47 Million CNY | 40.55% |
| 2011 Q2 | 129.44 Million CNY | 49.43% |
| 2011 Q1 | 86.63 Million CNY | -10.38% |
| 2011 Q3 | 127.23 Million CNY | -1.71% |
| 2010 Q1 | 62.06 Million CNY | 0.0% |
| 2010 Q4 | 96.66 Million CNY | 4.97% |
| 2010 Q3 | 92.08 Million CNY | -0.4% |
| 2010 Q2 | 92.45 Million CNY | 48.97% |
| 2010 FY | 343.27 Million CNY | 30.4% |
| 2009 FY | 263.25 Million CNY | 47.65% |
| 2008 FY | 178.29 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion CNY | -81.585% |
| Dirui Industrial Co.,Ltd. | 1.36 Billion CNY | -883.505% |
| Beijing Strong Biotechnologies, Inc. | 1.74 Billion CNY | -669.873% |
| Medicalsystem Biotechnology Co., Ltd. | 1.88 Billion CNY | -610.989% |
| Maccura Biotechnology Co.Ltd | 2.89 Billion CNY | -363.031% |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.76 Billion CNY | -384.945% |
| Guangdong Hybribio Biotech Co.,Ltd. | 1.1 Billion CNY | -1114.023% |
| BGI Genomics Co., Ltd. | 4.34 Billion CNY | -208.263% |
| Amoy Diagnostics Co., Ltd. | 1.03 Billion CNY | -1190.707% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 1.67 Billion CNY | -700.799% |